Actinobac Biomed, Inc.
Actinobac Biomed, Inc. is a biopharmaceutical company that focuses on the development of pharmaceutical technologies based upon the natural biologic agent leukotoxin (Leukothera™), which targets Leukocyte Function Antigen-1 (LFA-1) on white blood cells.
Categories
| Industry | Biomedical |
| Sub-industry | |
| Focus Areas | |
| Focus Areas - detailed |
University
| University | Rutgers |
| Principal Investigator | Scott Kachlany, Ph.D. - Center for Oral Infectious Diseases, School of Dental Medicine |
Company
| Web | http://actinobac.com/ |
| Address | |
| Phone | |
| Fax | |
Timeline
2009 - Founded
No files attached to this page.
Add a New Comment
